[1]
F. Li and W. Ma, “Study on the Impact of the Centralized Procurement Policy for Traditional Chinese Patent Medicines on the Innovation Performance of Listed Traditional Chinese Medicine Enterprises in China”, SJEMR, vol. 8, no. 6, pp. 1–10, Jun. 2026, doi: 10.54691/fgxvzh79.